AI-powered healthcare data analytics platform providing real-world evidence solutions for pharmaceutical and life sciences companies.
Concerto HealthAI leverages artificial intelligence and real-world data to provide evidence-based insights for the healthcare industry. The platform aggregates and analyzes clinical, claims, and other healthcare data to help pharmaceutical companies, payers, and providers make informed decisions about treatments, drug development, and patient outcomes. Their solutions include real-world evidence generation, market access support, and clinical trial optimization. The company focuses on transforming healthcare delivery through data-driven insights and AI-powered analytics.
Concerto HealthAI has received investment from 1 venture capital firm.
AI-powered healthcare data analytics platform providing real-world evidence solutions for pharmaceutical and life sciences companies.
Concerto HealthAI has received investment from F-Prime Capital (fka Fidelity Biosciences). These venture capital firms and investors provide both capital and strategic support.
Concerto HealthAI has raised $150M in total funding, with their most recent round being a Series B. The company operates in the Digital Health sector.
Concerto HealthAI was founded in 2018 and is headquartered in Boston, MA.
Concerto HealthAI operates in the Digital Health sector. AI-powered healthcare data analytics platform providing real-world evidence solutions for pharmaceutical and life sciences companies.
